Table 1.
The whole blood viscosity (WBV), plasma viscosity (PV), ADP-induced platelet maximum aggregation (PMAR) and thrombin time (TT), changes of treatment groups and normal group (x ± s, n = 8).
| Group | WBV (ηb/mPa•s) | PV (ηb/mPa•s) | PMAR (%) | TT (s) | |||
|---|---|---|---|---|---|---|---|
| 200 S−1 | 30 S−1 | 5 S−1 | 1 S−1 | 200 S−1 | |||
| Normal | 4.51 ± 0.50 | 5.55 ± 0.63 | 8.44 ± 1.05 | 16.45 ± 2.42 | 1.58 ± 0.09 | 15.67 ± 1.38 | 27.01 ± 1.53 |
| Model | 5.26 ± 0.84# | 6.49 ± 1.16# | 10.28 ± 1.84# | 20.67 ± 4.22# | 2.73 ± 0.11## | 17.70 ± 1.25# | 24.23 ± 2.39## |
| Aspirin | 4.78 ± 0.48 | 5.96 ± 0.65 | 8.91 ± 1.09* | 17.12 ± 2.44* | 1.60 ± 0.09** | 15.83 ± 1.44* | 26.69 ± 1.76* |
| XD | 4.45 ± 0.64* | 5.62 ± 0.78* | 8.47 ± 1.39* | 16.79 ± 3.14* | 1.60 ± 0.09** | 15.93 ± 1.23* | 26.50 ± 1.61* |
| XC | 5.14 ± 0.55 | 6.37 ± 0.74 | 9.83 ± 1.37 | 19.45 ± 3.10 | 1.66 ± 0.08** | 16.23 ± 1.58 | 25.59 ± 1.64 |
| XB | 5.02 ± 1.17 | 6.36 ± 1.55 | 9.71 ± 2.70 | 19.06 ± 6.19 | 1.65 ± 0.10** | 16.65 ± 1.83 | 25.71 ± 1.68 |
| XY | 5.27 ± 0.24 | 6.58 ± 0.35 | 10.25 ± 0.72 | 20.55 ± 1.93 | 1.71 ± 0.11** | 17.20 ± 2.33 | 25.91 ± 1.72 |
#
p < 0.05,
##
p < 0.01 compared to the normal group.
*
p < 0.05,
**
p < 0.01 compared to the model group.